Giordano Christopher Thomas: insider trades.
Giordano Christopher Thomas reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 2 open-market purchases ($20K) and 0 sales, across 1 company.
- Transactions
- 4
- Purchases (P)
- 2
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- Giordano Christopher Thomas
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Tenax Therapeutics, Inc. (TENX) | Director, Officer · CEO | 4 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-15 | Tenax Therapeutics, Inc. | P | 4,850 | $1.82 | 22,174 | Form 4 |
| 2026-09-11 | Tenax Therapeutics, Inc. | P | 6,000 | $1.88 | 17,324 | Form 4 |
| 2026-07-13 | Tenax Therapeutics, Inc. | M | 219 | $3.55 | 2,824 | Form 4 |
| 2026-07-13 | Tenax Therapeutics, Inc. | M | 8,500 | $5.94 | 11,324 | Form 4 |
Questions
What stock did Giordano Christopher Thomas buy or sell?
Giordano Christopher Thomas reported 4 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 2 open-market purchases ($20K) and 0 sales, across 1 company.
Is Giordano Christopher Thomas the same person as other filers with this name?
This page covers SEC CIK 1871714 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/giordano-christopher-thomas-1871714.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.